Knowledge (XXG)

Spinocerebellar ataxia

Source 📝

1986: 259: 75: 107:. SCA is hereditary, progressive, degenerative, and often fatal. There is no known effective treatment or cure. SCA can affect anyone of any age. The disease is caused by either a recessive or dominant gene. In many cases people are not aware that they carry a relevant gene until they have children who begin to show signs of having the disorder. Currently, research is being conducted at Universities, such as the University of Minnesota, to elucidate many of the unknown characteristics of the disease. 275: 2247:
and gait training for ataxia patients. General conditioning such as range-of-motion exercises and muscle strengthening would also be included in therapeutic exercise programmes. Research showed that spinocerebellar ataxia 2 (SCA2) patients with a mild stage of the disease gained significant improvement in static balance and neurological indices after six months of a physical therapy exercise training program.
1831: 2107:
In general, treatments are directed towards alleviating symptoms, not the disease itself. Many patients with hereditary or idiopathic forms of ataxia have other symptoms in addition to ataxia. Medications or other therapies might be appropriate for some of these symptoms, which could include tremor,
2246:
can assist patients in maintaining their level of independence through therapeutic exercise programmes. One recent research report demonstrated a gain of two SARA points (Scale for the Assessment and Rating of Ataxia) from physical therapy. In general, physical therapy emphasises postural balance
2154:
In addition, Dr. Beverly Davidson has been working on a methodology using RNAi technology to find a potential cure for over 2 decades. Her research began in the mid-1990s and progressed to work with mouse models about a decade later and most recently has moved to a study with non-human primates.
183:
for which specific genetic information is available are now known. Synonyms for autosomal-dominant cerebellar ataxias (ADCA) used prior to the current understanding of the molecular genetics were Marie's ataxia, inherited olivopontocerebellar atrophy, cerebello-olivary atrophy, or the more generic
321:
The first ataxia gene was identified in 1993 and called "Spinocerebellar ataxia type 1" (SCA1); later genes were called SCA2, SCA3, etc. Usually, the "type" number of "SCA" refers to the order in which the gene was found. At this time, there are at least 49 different gene mutations that have been
2263:
revealed that an intensive rehabilitation program with physical and occupational therapies for patients with degenerative cerebellar diseases can significantly improve functional gains in ataxia, gait, and activities of daily living. Some level of improvement was shown to be maintained 24 weeks
127:
and is often associated with poor coordination of hands, speech, and eye movements. A review of different clinical features among SCA subtypes was recently published describing the frequency of non-cerebellar features, like parkinsonism, chorea, pyramidalism, cognitive impairment, peripheral
2191:
Published case series studies have demonstrated the effects of acute treatment with N-Acetyl-Leucine for the treatment of inherited cerebellar ataxias, including spinocerebellar ataxias. These studies further demonstrated that the treatment is well tolerated, with a good safety profile. A
2509:
Figueroa, Karla P.; Gross, Caspar; Buena-Atienza, Elena; Paul, Sharan; Gandelman, Mandi; Kakar, Naseebullah; Sturm, Marc; Casadei, Nicolas; Admard, Jakob; Park, Joohyun; ZĂŒhlke, Christine; Hellenbroich, Yorck; Pozojevic, Jelena; Balachandran, Saranya; HĂ€ndler, Kristian (2024-04-29).
318:" disease for either the one-letter designation or codon for glutamine respectively. The threshold for symptoms in most forms of SCA is around 35, though for SCA3 it extends beyond 50. Most polyglutamine diseases are dominant due to the interactions of resulting polyQ tail. 307:, and several others. However, since not every SCA has been genetically identified some SCAs are still diagnosed by neurological examination, which may include a physical exam, family history, MRI scanning of the brain and spine, and spinal tap. 4114: 4099: 2180:(EMA) for the treatment of various genetic diseases, including spinocerebellar ataxias. N-Acetyl-Leucine has also been granted Orphan Drug Designations in the US and EU for the related inherited cerebellar ataxia ataxia-telangiectasia 2150:
status for their treatment. The information provided by BioBlast in their research indicates that they hope this treatment may prove efficacious in other SCA treatments that have similar pathology related to PolyA and PolyQ diseases.
5729: 5897: 218:
There have been reported cases where a polyglutamine expansion may lengthen when passed down, which often can result in an earlier age-of-onset and a more severe disease phenotype for individuals who inherit the disease
2340:
Rossi, M; Perez-Lloret, S; Doldan, L; Cerquetti, D; Balej, J; Millar Vernetti, P; Hawkes, H; Cammarota, A; Merello, M (2014). "Autosomal dominant cerebellar ataxias: A systematic review of clinical features".
2131:(ADLs). However, rehabilitation therapists can help patients to maximize their ability of self-care and delay deterioration to certain extent. Researchers are exploring multiple avenues for a cure including 4641: 5299: 5817: 2280: 5027: 5022: 2264:
post-treatment. Speech language pathologists may use both behavioral intervention strategies as well as augmentative and alternative communication devices to help patients with impaired speech.
3738:
Trujillo-Martín, M.Mar; Serrano-Aguilar, Pedro; Monton-Álvarez, Fernando; Carrillo-Fumero, Romen (2009). "Effectiveness and safety of treatments for degenerative ataxias: A systematic review".
5039: 5017: 2127:
CAG expansion, a longer expansion may lead to an earlier onset and a more radical progression of clinical symptoms. Typically, a person with this disease will eventually be unable to perform
103:
with multiple types, each of which could be considered a neurological condition in its own right. An estimated 150,000 people in the United States have a diagnosis of spinocerebellar ataxia
2169:
is an orally administered, modified amino acid that is being developed as a novel treatment for multiple rare and common neurological disorders by IntraBio Inc (Oxford, United Kingdom).
314:
diseases, which are caused when a disease-associated protein (i.e., ataxin-1, ataxin-3, etc.) contains a large number of repeats of glutamine residues, termed a polyQ sequence or a "CAG
5120: 4190: 4039: 4028: 4017: 2707: 1200:
dysarthria, slowly progressive gait and limb ataxia with severe dysmetria in the lower extremities, mild dysmetria in the upper extremities, dysphagia, and abnormal ocular movements
303:
has allowed precise identification of dozens of different SCAs and more tests are being added each year. In 2008, a genetic ataxia blood test developed to test for 12 types of SCA,
3570:
Strupp, Michael; Bayer, Otmar; Feil, Katharina; Straube, Andreas (February 2019). "Prophylactic treatment of migraine with and without aura with acetyl-dl-leucine: a case series".
2158:
Finally, another gene transfer technology discovered in 2011 has also been shown by Boudreau et al. to hold great promise and offers yet another avenue to a potential future cure.
2104:
There is no cure for spinocerebellar ataxia, which is currently considered to be a progressive and irreversible disease, although not all types cause equally severe disability.
3072: 274: 5292: 192:
characterized by the slow degeneration of certain areas of the brain. There are three forms of spinocerebellar degeneration: Types 1, 2, 3. Symptoms begin during adulthood.)
3545: 4386: 211:. Disorder subdivisions: Friedreich's ataxia, spinocerebellar ataxia, ataxia telangiectasia, vasomotor ataxia, vestibulocerebellar, ataxiadynamia, ataxiophemia, and 3781:
Miyai, I.; Ito, M.; Hattori, N.; Mihara, M.; Hatakenaka, M.; Yagura, H.; Sobue, G.; Nishizawa, M.; Cerebellar Ataxia Rehabilitation Trialists Collaboration (2011).
136:, loss of fine coordination of muscle movements leading to unsteady and clumsy motion, and other symptoms. Ocular deficits can be quantified using the SODA scale. 5285: 4381: 258: 5113: 4183: 2298: 3097: 5009: 3707: 2251:
may assist patients with incoordination or ataxia issues through the use of adaptive devices. Such devices may include a cane, crutches, walker, or
5106: 4999: 4176: 4023: 2702: 4979: 4652: 4012: 2998:. In Adam, Margaret P.; Ardinger, Holly H.; Pagon, Roberta A.; Wallace, Stephanie E.; Bean, Lora J.H.; Stephens, Karen; Amemiya, Anne (eds.). 2594: 5892: 5872: 5004: 4636: 2906: 5902: 5771: 5417: 5158: 4842: 4830: 4292: 180: 3238:"Rational Design of Therapeutic siRNAs: Minimizing Off-targeting Potential to Improve the Safety of RNAi Therapy for Huntington's Disease" 2285: 48: 4129: 3949: 3940: 3076: 2929: 1975: 139:
The symptoms of an ataxia vary with the specific type and with the individual patient. In many cases a person with ataxia retains full
5743: 5395: 5308: 5061: 4994: 4549: 2181: 2173: 4764: 4567: 2200: 5442: 3853:
Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A (1993). Pagon RA, Bird TD, Dolan CR, et al. (eds.).
3440:
Schniepp, Roman; Strupp, Michael; Wuehr, Max; Jahn, Klaus; Dieterich, Marianne; Brandt, Thomas; Feil, Katharina (December 2016).
1842: 5367: 3549: 5361: 4883: 3615:"Motor Training in Degenerative Spinocerebellar Disease: Ataxia-Specific Improvements by Intensive Physiotherapy and Exergames" 3023:"Motor Training in Degenerative Spinocerebellar Disease: Ataxia-Specific Improvements by Intensive Physiotherapy and Exergames" 2785:
Mosemiller, A.K.; Dalton, J.C.; Day, J.W.; Ranum, L.P.W. (2003). "Molecular genetics of spinocerebellar ataxia type 8 (SCA8)".
5785: 5188: 5150: 4398: 4374: 4204: 849: 228: 5456: 5353: 4590: 3383: 3359: 3310: 3285: 5907: 5660: 5632: 5141: 5077: 4962: 4878: 4820: 4369: 4072: 4059: 3136: 2877: 2855: 2833: 2768: 2746: 2724: 2685: 2663: 2641: 2259:. Other devices are available to assist with writing, feeding, and self care if hand and arm coordination are impaired. A 2220: 2192:
multinational clinical trial investigating N-Acetyl-L-Leucine for the treatment of a related inherited cerebellar ataxia,
2124: 2080: 2055: 2030: 2005: 1956: 1931: 1906: 1881: 1856: 1822: 1800: 1775: 1750: 1725: 1700: 1675: 1650: 1625: 1600: 1575: 1550: 1525: 1500: 1475: 1450: 1425: 1400: 1375: 1350: 1325: 1300: 590: 364: 5046: 4420: 212: 5312: 4556: 5277: 5034: 4584: 4256: 2128: 2120:, among others. Both onset of initial symptoms and duration of disease are variable. If the disease is caused by a 5505: 4926: 2193: 5853: 5129: 4984: 4952: 4904: 4753: 4332: 4034: 2512:"A GGC-repeat expansion in ZFHX3 encoding polyglycine causes spinocerebellar ataxia type 4 and impairs autophagy" 2260: 2185: 2177: 240: 5801: 5051: 4825: 4239: 4140: 2881: 2859: 2837: 2772: 2750: 2728: 2689: 2667: 2645: 5056: 3335: 5163: 5133: 4989: 4745: 4563: 4415: 4405: 4249: 2248: 977: 869: 841: 763: 722: 674: 627: 513: 450: 400: 224: 2138:
On January 18, 2017, BioBlast Pharma announced completion of Phase 2a clinical trials of their medication,
5912: 5204: 5177: 4921: 4868: 4544: 4516: 4364: 2224: 1052: 476: 304: 189: 3714: 2208: 2155:
The results from her most recent research "are supportive of clinical application of this gene therapy".
4936: 4810: 4628: 4606: 4521: 4444: 4354: 4341: 4266: 3189:"Broad distribution of ataxin 1 silencing in rhesus cerebella for spinocerebellar ataxia type 1 therapy" 3112:"Bioblast Announces Phase 2a Results of Trehalose in Patients with Spinocerebellar Ataxia Type 3 (SCA3)" 704: 609: 482: 204: 1179:
ataxia, hyperrheflexia, dysarthria, fasciculations of the tongue with subsequent wasting of the tongue
2872: 2850: 2828: 5470: 5168: 4873: 4690: 4579: 2763: 2741: 2719: 2680: 2658: 2636: 961: 660: 315: 4802: 4449: 4304: 4244: 4118: 2601: 2243: 311: 236: 168: 92: 74: 2199:
IntraBio is also conducting parallel clinical trials with N-Acetyl-L-Leucine for the treatment of
5604: 5563: 5543: 5527: 5247: 5211: 5197: 4972: 4957: 4945: 4695: 4646: 4483: 4346: 4234: 3993: 3964:""Novel CACNA1A Variant p.Cys256Phe Disrupts Disulfide Bonds and Causes Spinocerebellar Ataxia."" 3812: 3763: 3689: 3595: 3533: 3515: 3497: 2810: 2440: 2376: 2228: 2216: 2204: 1139: 1089: 903: 664: 494: 389: 265: 164: 4168: 4735: 4701: 4673: 4664: 4596: 4572: 4439: 4287: 4151: 3985: 3925: 3902: 3879: 3860: 3842: 3804: 3755: 3681: 3646: 3587: 3473: 3442:"Acetyl-DL-leucine improves gait variability in patients with cerebellar ataxia—a case series" 3267: 3218: 3091: 3054: 3003: 2976: 2912: 2902: 2802: 2576: 2527: 2491: 2432: 2405:— Gives a concise description of SCA, along with a picture of shrunken degenerated cerebellum. 2368: 2109: 613: 200: 96: 63: 2994:
Cruts, Marc; Engelborghs, Sebastiaan; van der Zee, Julie; Van Broeckhoven, Christine (1993).
128:
neuropathy, seizures, among others. As with other forms of ataxia, SCA frequently results in
5789: 5713: 4858: 4729: 4724: 4509: 4504: 3975: 3794: 3747: 3673: 3636: 3626: 3579: 3463: 3453: 3420: 3257: 3249: 3208: 3200: 3163:"RNA Interference for Treating Huntington's Disease: An Interview with Dr. Beverly Davidson" 3044: 3034: 2966: 2958: 2794: 2566: 2558: 2519: 2481: 2471: 2424: 2358: 2350: 2212: 2143: 2132: 1135: 1131: 701: 489: 124: 120: 3111: 2001: 1261: 1238: 1234: 1230: 1226: 1222: 1218: 1214: 1111: 1069: 1026: 989: 985: 239:
in protein. The expansion of CAG repeats over successive generations appears to be due to
5486: 5098: 4780: 4471: 4068: 4055: 2076: 2051: 2026: 1952: 1927: 1902: 1877: 1852: 1818: 1771: 1746: 1721: 1696: 1671: 1646: 1621: 1596: 1571: 1546: 1521: 1496: 1471: 1446: 1421: 1396: 1371: 1346: 1321: 300: 244: 172: 140: 100: 3664:
Marsden, J.; Harris, C. (2011). "Cerebellar ataxia: Pathophysiology and rehabilitation".
1296: 299:
A few SCAs remain unspecified and can not be precisely diagnosed, but in the last decade
5831: 5704: 4837: 4786: 4614: 4323: 4200: 3641: 3614: 3468: 3441: 3262: 3237: 3213: 3188: 3049: 3022: 2971: 2946: 2571: 2546: 2486: 2459: 2117: 1147: 281: 208: 17: 1796: 5886: 5549: 4863: 4815: 4685: 4454: 4410: 4261: 3997: 3974:(2). Movement disorders: official journal of the Movement Disorder Society: 401–404. 3532:
for "N-Acetyl-L-Leucine for GM2 Gangliosdisosis (Tay-Sachs and Sandhoff Disease)" at
2511: 2444: 2166: 1151: 757: 712: 583: 552: 4123: 3816: 3767: 3693: 3599: 2460:"On the wrong DNA track: Molecular mechanisms of repeat-mediated genome instability" 2415:
Shaikh, A; Ji Soo, Kim (2022). "Scale for Ocular motor Disorders in Ataxia (SODA)".
2380: 2316: 5579: 5557: 4359: 4229: 4212: 4076: 4063: 2814: 2084: 2059: 2034: 2009: 1960: 1935: 1910: 1885: 1860: 1826: 1804: 1779: 1754: 1729: 1704: 1679: 1654: 1629: 1604: 1579: 1554: 1529: 1504: 1479: 1454: 1429: 1404: 1379: 1354: 1329: 1304: 4050: 3528: 3510: 3492: 4145: 3854: 3289: 2562: 5616: 4318: 4279: 4221: 4045: 2995: 2398: 2147: 1143: 786: 708: 486: 4156: 3919: 2523: 2394: 47: 5779: 5765: 5331: 4429: 4299: 4108: 3896: 3873: 3836: 3583: 3458: 3425: 3408: 2962: 2476: 2428: 2252: 2113: 1127: 1093: 1044: 1013: 1006: 575: 540: 435: 248: 160: 133: 104: 55: 3799: 3782: 3677: 2531: 2403:. Bethesda MD: National Center for Biotechnology Information. 1998. NBK22234. 2172:
N-Acetyl-Leucine has been granted multiple orphan drug designations from the
5847: 5347: 4539: 4490: 4478: 4461: 4393: 3783:"Cerebellar Ataxia Rehabilitation Trial in Degenerative Cerebellar Diseases" 3187:
Keiser, M. S.; Kordower, J. H.; Gonzalez-Alegre, P; Davidson, B. L. (2015).
2947:"Neurological disorders associated with DNA strand-break processing enzymes" 2139: 2121: 899: 68: 3989: 3929: 3906: 3883: 3864: 3846: 3808: 3759: 3685: 3650: 3591: 3477: 3271: 3222: 3204: 3058: 3007: 2996:"C9orf72-Related Amyotrophic Lateral Sclerosis and Frontotemporal Dementia" 2980: 2806: 2580: 2495: 2436: 2372: 3918:
Brussino, Alessandro; Brusco, Alfredo; DĂŒrr, Alexandra (7 February 2013).
3631: 3039: 207:, ataxia with vitamin E deficiency, ataxia with oculomotor apraxia (AOA), 5755: 5672: 5327: 4719: 4711: 4677: 4531: 4434: 3236:
Boudreau, Ryan L; Spengler, Ryan M; Davidson, Beverly L (December 2011).
2899:
Evaluation and Management of Ataxic Disorders: An Overview for Physicians
2299:"Ataxias and Cerebellar or Spinocerebellar Degeneration Information Page" 2232: 1835: 1288:
Anemia, sideroblastic spinocerebellar ataxia; Pagon Bird Detter syndrome
1048: 1009: 910:
or parts of muscles, without any rhythm or pattern, occurring in various
827: 678: 617: 543: 506: 438: 404: 385: 152: 3253: 2595:"FREQUENTLY ASKED QUESTIONS ABOUT... Gene Testing for Hereditary Ataxia" 5644: 5626: 2945:
Jiang, Bingcheng; Glover, J.N. Mark; Weinfeld, Michael (January 2017).
2363: 801: 747: 632: 594: 522: 129: 4091: 3980: 3963: 3751: 2798: 2354: 5825: 5811: 5723: 5682: 5588: 5521: 5389: 4758: 4499: 4466: 4103: 2135:(RNAi) technology, the use of stem cells, and several other avenues. 1123: 1097: 1085: 1037: 947: 907: 831: 822: 752: 743: 731: 560: 501: 220: 116: 3137:"The Orphan Genetic Disease Company: Bioblast Pharma Ltd. June 2016" 1993:
Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy
5014:
Spinal muscular atrophy with lower extremity predominance (SMALED)
3514:
for "N-Acetyl-L-Leucine for Niemann-Pick Disease, Type C (NPC)" at
2547:"Repeat instability during DNA repair: Insights from model systems" 2215:
disease). Future opportunities to develop N-Acetyl-Leucine include
5737: 5654: 5598: 5464: 5450: 5436: 5379: 2916: 1970: 1184: 1156: 1073: 1041: 993: 926: 911: 883: 863: 853: 771: 687: 644: 459: 413: 368: 5898:
Systemic atrophies primarily affecting the central nervous system
5499: 5411: 5341: 4134: 3953: 3944: 2933: 2256: 2071: 2046: 2021: 1996: 1979: 1947: 1922: 1897: 1872: 1847: 1791: 1766: 1741: 1716: 1691: 1666: 1641: 1616: 1591: 1566: 1541: 1516: 1491: 1466: 1441: 1416: 1391: 1366: 1341: 1316: 1291: 1275: 1257: 1253: 1249: 1245: 1205: 1162: 1055: 944: 940: 819: 815: 636: 444: 156: 5281: 5102: 4172: 1260:), but only the first of these has so far been tied to a gene ( 3945:
Spinocerebellar Ataxia, Autosomal Recessive 1; SCAR1 - 606002
357: 232: 3162: 1969:
Spinocerebellar ataxia, autosomal recessive 21 - mutation in
155:
ataxias are categorized by mode of inheritance and causative
3496:
for "N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T)" at
4024:
Spinocerebellar Ataxias including Machado-Joseph Disease
2703:
Spinocerebellar Ataxias including Machado-Joseph Disease
2624: 1313:
Friedreich's ataxia; Spinocerebellar ataxia, Friedreich
3872:
Moreira, Maria-Ceu; Koenig, Michel (December 8, 2011).
2303:
National Institute on Neurological Disorders and Stroke
2142:, in the treatment of SCA3. BioBlast has received FDA 620:
can appear for the first time as late as 65 years old.
41:
Spinocerebellar atrophy or Spinocerebellar degeneration
2901:. Minneapolis: National Ataxia Foundation. p. 6. 830:(loss of normal motor function, resulting in impaired 4013:
Ataxia and Cerebellar or Spinocerebellar Degeneration
657:(1–45; early onset correlates with shorter duration) 325:
The following is a list of some of the many types of
163:
locus. The hereditary ataxias can be inherited in an
4081: 1813:
Spinocerebellar ataxia amyotrophy deafness syndrome
5800: 5754: 5712: 5703: 5671: 5643: 5615: 5587: 5578: 5485: 5428: 5378: 5326: 5319: 5257: 5239: 5187: 5149: 5140: 4935: 4912: 4903: 4896: 4851: 4801: 4773: 4744: 4710: 4672: 4661: 4627: 4605: 4530: 4340: 4331: 4317: 4277: 4220: 4211: 4085: 3002:. Seattle (WA): University of Washington, Seattle. 62: 37: 32: 229:repeat expansion of the trinucleotide sequence CAG 199:disorders in which ataxia is a prominent feature: 3859:. Seattle WA: University of Washington, Seattle. 1413:Spinocerebellar ataxia 3; Machado Joseph disease 188:is a rare inherited neurological disorder of the 284:disorders in which ataxia is a prominent feature 3384:"Search Orphan Drug Designations and Approvals" 3360:"Search Orphan Drug Designations and Approvals" 3311:"Search Orphan Drug Designations and Approvals" 3409:"MEDLINE, PubMed, PubMed Central, and the NLM" 1944:Spinocerebellar ataxia, autosomal recessive 6 1919:Spinocerebellar ataxia, autosomal recessive 5 1894:Spinocerebellar ataxia, autosomal recessive 4 1869:Spinocerebellar ataxia, autosomal recessive 3 5293: 5114: 4184: 2317:"Spinocerebellar Ataxia | Research Computing" 1843:Spinocerebellar ataxia, autosomal recessive 1 859:Childhood or adulthood depending on mutation 8: 3962:Nikonishyna, Yuliia V.; et al. (2022). 3708:"SCA2 information sheet from www.ataxia.org" 227:. Several types of SCA are characterized by 2545:Usdin K, House NC, Freudenreich CH (2015). 310:Many SCAs below fall under the category of 5709: 5584: 5491: 5323: 5300: 5286: 5278: 5146: 5121: 5107: 5099: 4909: 4900: 4669: 4337: 4328: 4217: 4191: 4177: 4169: 4082: 2892: 2890: 1244:Four X-linked types have been described ( 143:but progressively loses physical control. 73: 46: 29: 3979: 3798: 3640: 3630: 3613:Synofzik, Matthis; Ilg, Winfried (2014). 3467: 3457: 3424: 3261: 3212: 3048: 3038: 3021:Synofzik, Matthis; Ilg, Winfried (2014). 2970: 2570: 2485: 2475: 2362: 393:(note: saccades relates to eye movement) 5174:Spinocerebellar ataxia 1, 2, 3, 6, 7, 17 3334:FRANCISCO, Estela Miranda (2018-12-20). 1268: 331: 3935: 3912: 3889: 2273: 1338:Infantile onset Spinocerebellar ataxia 254: 5772:Congenital generalized lipodystrophy 3 4980:Distal hereditary motor neuronopathies 4653:Template:Demyelinating diseases of CNS 3096:: CS1 maint: archived copy as title ( 3089: 2458:Khristich AN, Mirkin SM (March 2020). 1146:, extensor plantar responses, reduced 184:term "spinocerebellar degeneration." ( 3924:. University of Washington, Seattle. 3901:. University of Washington, Seattle. 3878:. University of Washington, Seattle. 3875:Ataxia with Oculomotor Apraxia Type 2 3841:. University of Washington, Seattle. 3787:Neurorehabilitation and Neural Repair 715:), instability, lack of coordination 181:autosomal dominant cerebellar ataxias 7: 5744:Hemophagocytic lymphohistiocytosis 4 5159:Dentatorubral-pallidoluysian atrophy 4831:Idiopathic intracranial hypertension 2951:Mechanisms of Ageing and Development 2417:Journal of the Neurological Sciences 2400:Genes and Disease [Internet] 2068:Spinocerebellar ataxia, X-linked, 4 2043:Spinocerebellar ataxia, X-linked, 3 2018:Spinocerebellar ataxia, X-linked, 2 223:. This falls under the category of 123:characterized by slowly progressive 3950:Online Mendelian Inheritance in Man 3941:Online Mendelian Inheritance in Man 2930:Online Mendelian Inheritance in Man 2182:U.S. Food & Drug Administration 2174:U.S. Food & Drug Administration 1976:Online Mendelian Inheritance in Man 5396:Cranio-lenticulo-sutural dysplasia 5309:Inherited disorders of trafficking 5062:Infantile progressive bulbar palsy 4069:Spinocerebellar ataxia dysmorphism 3835:Bird, Thomas D (23 January 2014). 789:(able to walk about on one's own) 25: 5786:Limb-girdle muscular dystrophy 2B 4765:Template:Cerebrovascular diseases 4568:Frontotemporal lobar degeneration 5661:Hereditary spastic paraplegia 10 5443:X-linked intellectual disability 4785:For more detailed coverage, see 4763:For more detailed coverage, see 4734:For more detailed coverage, see 4700:For more detailed coverage, see 4651:For more detailed coverage, see 3895:Pulst, Stefan-M (1 March 2012). 3161:Veritas, Gene (17 August 2013). 273: 257: 5633:Hereditary spastic paraplegia 4 2787:Cytogenetic and Genome Research 1173:5th and 6th decade (adulthood) 3921:Spinocerebellar Ataxia Type 28 3898:Spinocerebellar Ataxia Type 13 3856:GeneReviews [Internet] 1165:) located at chromosome 20p13 1: 5078:Amyotrophic lateral sclerosis 4963:Hereditary spastic paraplegia 4821:Normal pressure hydrocephalus 3619:BioMed Research International 3027:BioMed Research International 2551:Crit. Rev. Biochem. Mol. Biol 2343:European Journal of Neurology 2221:amyotrophic lateral sclerosis 348:What the patient experiences 5893:Autosomal dominant disorders 5873:vesicular transport proteins 5313:vesicular transport proteins 5047:Progressive muscular atrophy 4051:Olivopontocerebellar atrophy 2563:10.3109/10409238.2014.999192 2286:Dorland's Medical Dictionary 980:, 6q (TATA-binding protein) 429:Diminished velocity saccades 264:There are numerous types of 213:olivopontocerebellar atrophy 186:Spinocerebellar degeneration 58:(in blue) of the human brain 5903:Neurodegenerative disorders 5457:Hermansky–Pudlak syndrome 2 4557:Primary progressive aphasia 2201:Niemann-Pick disease type C 119:(SCA) is one of a group of 5929: 5151:Polyglutamine (PolyQ), CAG 4879:Hashimoto's encephalopathy 4585:Posterior cortical atrophy 4406:Striatonigral degeneration 4257:Cavernous sinus thrombosis 3838:Hereditary Ataxia Overview 2897:Perlman, Susan L. (2016). 2524:10.1038/s41588-024-01719-5 1788:Spinocerebellar ataxia 35 1763:Spinocerebellar ataxia 30 1738:Spinocerebellar ataxia 28 1713:Spinocerebellar ataxia 26 1688:Spinocerebellar ataxia 25 1663:Spinocerebellar ataxia 23 1638:Spinocerebellar ataxia 21 1613:Spinocerebellar ataxia 20 1588:Spinocerebellar ataxia 19 1563:Spinocerebellar ataxia 18 1538:Spinocerebellar ataxia 13 237:polyglutamine repeat tract 5868: 5854:Distal muscular dystrophy 5842: 5538: 5516: 5494: 5406: 5354:Hermansky–Pudlak syndrome 5266:Spinocerebellar ataxia 10 5248:Myotonic dystrophy type 2 5226:Spinocerebellar ataxia 12 5212:Myotonic dystrophy type 1 5130:Non-Mendelian inheritance 4985:Spinal muscular atrophies 4953:Primary lateral sclerosis 4811:Intracranial hypertension 4591:Creutzfeldt–Jakob disease 4056:Spinocerebellar ataxia 27 3584:10.1007/s00415-018-9155-6 3459:10.1186/s40673-016-0046-2 3426:10.1080/17521740701702115 3340:European Medicines Agency 2963:10.1016/j.mad.2016.07.009 2477:10.1074/jbc.REV119.007678 2429:10.1016/j.jns.2022.120472 2261:randomised clinical trial 2186:European Medicines Agency 2178:European Medicines Agency 1513:Spinocerebellar ataxia 8 1488:Spinocerebellar ataxia 7 1463:Spinocerebellar ataxia 5 1438:Spinocerebellar ataxia 4 1388:Spinocerebellar ataxia 2 1363:Spinocerebellar ataxia 1 241:slipped strand mispairing 54: 45: 5802:Vacuolar protein sorting 5689:Spinocerebellar ataxia 5 5368:ChĂ©diak–Higashi syndrome 5219:Spinocerebellar ataxia 8 5052:Progressive bulbar palsy 4843:Intracranial hypotension 4826:Choroid plexus papilloma 4240:Herpesviral encephalitis 4046:MedlinePlus Encyclopedia 3954:Senataxin; SETX - 608465 3800:10.1177/1545968311425918 3678:10.1177/0269215510382495 3446:Cerebellum & Ataxias 3407:Cross, Jo (April 2006). 2395:"Spinocerebellar ataxia" 2281:"spinocerebellar ataxia" 2255:for those with impaired 4564:Frontotemporal dementia 4250:Encephalitis lethargica 4035:Multiple System Atrophy 3666:Clinical Rehabilitation 2249:Occupational therapists 870:Intellectual disability 707:(a rapid, involuntary, 485:(a rapid, involuntary, 280:There are five typical 195:There are five typical 18:Spinocerebellar ataxias 5178:Machado-Joseph disease 4869:Hepatic encephalopathy 3526:Clinical trial number 3508:Clinical trial number 3490:Clinical trial number 3388:www.accessdata.fda.gov 3364:www.accessdata.fda.gov 3315:www.accessdata.fda.gov 477:Machado-Joseph disease 327:Spinocerebellar ataxia 190:central nervous system 125:incoordination of gait 85:Spinocerebellar ataxia 33:Spinocerebellar ataxia 4927:Ataxia–telangiectasia 4884:Static encephalopathy 4607:Mitochondrial disease 4445:Spasmodic torticollis 4355:Basal ganglia disease 3142:. Bioblast Pharma Ltd 2225:restless leg syndrome 2194:ataxia-telangiectasia 205:ataxia-telangiectasia 5908:Cytoskeletal defects 5605:Griscelli syndrome 1 5564:Griscelli syndrome 3 5528:Griscelli syndrome 2 5164:Huntington's disease 4874:Toxic encephalopathy 4580:Lewy bodies dementia 3572:Journal of Neurology 3205:10.1093/brain/awv292 2125:trinucleotide repeat 1161:transglutaminase 6 ( 661:Macular degeneration 316:trinucleotide repeat 225:genetic anticipation 5205:Friedreich's ataxia 4922:Friedreich's ataxia 4305:Meningoencephalitis 4245:Limbic encephalitis 3632:10.1155/2014/583507 3254:10.1038/mt.2011.185 3040:10.1155/2014/583507 2244:Physical therapists 421:(<10 to >60) 376:(<10 to >60) 305:Friedreich's ataxia 282:autosomal recessive 197:autosomal-recessive 169:autosomal recessive 5790:Long QT syndrome 9 5198:Fragile X syndrome 4958:Pseudobulbar palsy 4696:Status epilepticus 4647:Multiple sclerosis 4484:Myoclonic epilepsy 4347:movement disorders 4293:Acute disseminated 4235:Viral encephalitis 3968:Movement Disorders 3740:Movement Disorders 3534:ClinicalTrials.gov 3516:ClinicalTrials.gov 3498:ClinicalTrials.gov 2229:multiple sclerosis 2217:Lewy body dementia 2205:GM2 gangliosidosis 1140:pseudobulbar palsy 665:upper motor neuron 495:upper motor neuron 390:upper motor neuron 268:cerebellar ataxias 266:autosomal-dominant 165:autosomal dominant 111:Signs and symptoms 5880: 5879: 5864: 5863: 5699: 5698: 5574: 5573: 5481: 5480: 5320:Vesicle formation 5275: 5274: 5235: 5234: 5189:Non-polyglutamine 5096: 5095: 5092: 5091: 5088: 5087: 4892: 4891: 4797: 4796: 4736:Template:Headache 4702:Template:Epilepsy 4623: 4622: 4597:Vascular dementia 4440:Status dystonicus 4313: 4312: 4288:Encephalomyelitis 4166: 4165: 3981:10.1002/mds.28835 3752:10.1002/mds.22564 3413:Editors' Bulletin 3248:(12): 2169–2177. 3242:Molecular Therapy 3199:(12): 3555–3566. 2957:(Pt A): 130–140. 2908:978-0-943218-14-4 2799:10.1159/000072852 2470:(13): 4134–4170. 2355:10.1111/ene.12350 2196:, began in 2019. 2092: 2091: 1211: 1210: 866:(a kind of gene) 388:, slow saccades, 345:(Range in Years) 340:(Range in Years) 201:Friedreich ataxia 121:genetic disorders 105:at any given time 82: 81: 27:Medical condition 16:(Redirected from 5920: 5714:Synaptic vesicle 5710: 5585: 5492: 5324: 5302: 5295: 5288: 5279: 5147: 5123: 5116: 5109: 5100: 4910: 4901: 4859:Brain herniation 4670: 4510:Intention tremor 4505:Essential tremor 4370:Postencephalitic 4338: 4329: 4218: 4199:Diseases of the 4193: 4186: 4179: 4170: 4083: 4001: 3983: 3933: 3910: 3887: 3868: 3850: 3821: 3820: 3802: 3778: 3772: 3771: 3735: 3729: 3728: 3726: 3725: 3719: 3713:. Archived from 3712: 3704: 3698: 3697: 3661: 3655: 3654: 3644: 3634: 3610: 3604: 3603: 3567: 3561: 3560: 3558: 3557: 3548:. Archived from 3542: 3536: 3524: 3518: 3506: 3500: 3488: 3482: 3481: 3471: 3461: 3437: 3431: 3430: 3428: 3404: 3398: 3397: 3395: 3394: 3380: 3374: 3373: 3371: 3370: 3356: 3350: 3349: 3347: 3346: 3331: 3325: 3324: 3322: 3321: 3307: 3301: 3300: 3298: 3297: 3288:. Archived from 3282: 3276: 3275: 3265: 3233: 3227: 3226: 3216: 3184: 3178: 3177: 3175: 3173: 3158: 3152: 3151: 3149: 3147: 3141: 3133: 3127: 3126: 3124: 3122: 3108: 3102: 3101: 3095: 3087: 3085: 3084: 3075:. Archived from 3069: 3063: 3062: 3052: 3042: 3018: 3012: 3011: 2991: 2985: 2984: 2974: 2942: 2936: 2927: 2921: 2920: 2894: 2885: 2869: 2863: 2847: 2841: 2825: 2819: 2818: 2782: 2776: 2760: 2754: 2738: 2732: 2716: 2710: 2699: 2693: 2677: 2671: 2655: 2649: 2633: 2627: 2622: 2616: 2615: 2613: 2612: 2606: 2600:. Archived from 2599: 2591: 2585: 2584: 2574: 2542: 2536: 2535: 2506: 2500: 2499: 2489: 2479: 2455: 2449: 2448: 2412: 2406: 2404: 2391: 2385: 2384: 2366: 2337: 2331: 2330: 2328: 2327: 2313: 2307: 2306: 2295: 2289: 2278: 2167:N-Acetyl-Leucine 2162:N-Acetyl-Leucine 2133:RNA interference 2002:Disease ID 10000 1269: 1136:intention tremor 1132:ocular dysmetria 1053:gastrointestinal 782:Normal lifespan 762:pentanucleotide 698:Normal lifespan 667:, slow saccades 343:Average Duration 332: 277: 261: 115:Spinocerebellar 78: 77: 50: 30: 21: 5928: 5927: 5923: 5922: 5921: 5919: 5918: 5917: 5883: 5882: 5881: 5876: 5860: 5838: 5796: 5750: 5730:CEDNIK syndrome 5695: 5667: 5639: 5611: 5570: 5534: 5512: 5477: 5424: 5402: 5374: 5315: 5306: 5276: 5271: 5258:Pentanucleotide 5253: 5240:Tetranucleotide 5231: 5183: 5169:Kennedy disease 5136: 5127: 5097: 5084: 5010:Congenital DSMA 4931: 4888: 4847: 4793: 4781:Sleep disorders 4769: 4746:Cerebrovascular 4740: 4706: 4663: 4657: 4619: 4601: 4526: 4472:Choreoathetosis 4345: 4322: 4309: 4273: 4207: 4197: 4167: 4162: 4161: 4094: 4008: 3961: 3958: 3917: 3894: 3871: 3852: 3834: 3830: 3828:Further reading 3825: 3824: 3780: 3779: 3775: 3737: 3736: 3732: 3723: 3721: 3717: 3710: 3706: 3705: 3701: 3663: 3662: 3658: 3612: 3611: 3607: 3569: 3568: 3564: 3555: 3553: 3544: 3543: 3539: 3525: 3521: 3507: 3503: 3489: 3485: 3439: 3438: 3434: 3406: 3405: 3401: 3392: 3390: 3382: 3381: 3377: 3368: 3366: 3358: 3357: 3353: 3344: 3342: 3333: 3332: 3328: 3319: 3317: 3309: 3308: 3304: 3295: 3293: 3284: 3283: 3279: 3235: 3234: 3230: 3186: 3185: 3181: 3171: 3169: 3160: 3159: 3155: 3145: 3143: 3139: 3135: 3134: 3130: 3120: 3118: 3110: 3109: 3105: 3088: 3082: 3080: 3073:"Archived copy" 3071: 3070: 3066: 3020: 3019: 3015: 2993: 2992: 2988: 2944: 2943: 2939: 2928: 2924: 2909: 2896: 2895: 2888: 2870: 2866: 2848: 2844: 2826: 2822: 2793:(1–4): 175–83. 2784: 2783: 2779: 2761: 2757: 2739: 2735: 2717: 2713: 2700: 2696: 2678: 2674: 2656: 2652: 2634: 2630: 2623: 2619: 2610: 2608: 2604: 2597: 2593: 2592: 2588: 2544: 2543: 2539: 2516:Nature Genetics 2508: 2507: 2503: 2457: 2456: 2452: 2414: 2413: 2409: 2393: 2392: 2388: 2339: 2338: 2334: 2325: 2323: 2315: 2314: 2310: 2297: 2296: 2292: 2279: 2275: 2270: 2241: 2164: 2118:sleep disorders 2102: 2097: 2077:Disease ID 9980 2052:Disease ID 9981 2027:Disease ID 9978 1953:Disease ID 4954 1928:Disease ID 9977 1903:Disease ID 4952 1878:Disease ID 9971 1853:Disease ID 4949 1819:Disease ID 2451 1772:Disease ID 9975 1747:Disease ID 9951 1722:Disease ID 9995 1697:Disease ID 9996 1672:Disease ID 9950 1647:Disease ID 9999 1622:Disease ID 9997 1597:Disease ID 9969 1572:Disease ID 9976 1547:Disease ID 9611 1522:Disease ID 4956 1497:Disease ID 4955 1472:Disease ID 4953 1447:Disease ID 9970 1422:Disease ID 6801 1397:Disease ID 4072 1372:Disease ID 4071 1347:Disease ID 4062 1322:Disease ID 6468 1213:Others include 933: 895: 890: 826: 808: 778: 761: 694: 656: 651: 631: 616: 601: 567: 529: 504: 497: 493: 492:of the eyeball) 480: 471: 466: 430: 425: 420: 392: 380: 375: 355: 344: 339: 301:genetic testing 297: 292: 285: 278: 269: 262: 245:DNA replication 235:that encodes a 173:X-linked manner 149: 141:mental capacity 113: 101:genetic disease 72: 28: 23: 22: 15: 12: 11: 5: 5926: 5924: 5916: 5915: 5910: 5905: 5900: 5895: 5885: 5884: 5878: 5877: 5869: 5866: 5865: 5862: 5861: 5859: 5858: 5857: 5856: 5843: 5840: 5839: 5837: 5836: 5835: 5834: 5832:Cohen syndrome 5822: 5821: 5820: 5807: 5805: 5798: 5797: 5795: 5794: 5793: 5792: 5776: 5775: 5774: 5761: 5759: 5752: 5751: 5749: 5748: 5747: 5746: 5734: 5733: 5732: 5719: 5717: 5707: 5705:Vesicle fusion 5701: 5700: 5697: 5696: 5694: 5693: 5692: 5691: 5678: 5676: 5669: 5668: 5666: 5665: 5664: 5663: 5650: 5648: 5641: 5640: 5638: 5637: 5636: 5635: 5622: 5620: 5613: 5612: 5610: 5609: 5608: 5607: 5594: 5592: 5582: 5576: 5575: 5572: 5571: 5569: 5568: 5567: 5566: 5554: 5553: 5552: 5539: 5536: 5535: 5533: 5532: 5531: 5530: 5517: 5514: 5513: 5511: 5510: 5509: 5508: 5495: 5489: 5483: 5482: 5479: 5478: 5476: 5475: 5474: 5473: 5461: 5460: 5459: 5447: 5446: 5445: 5432: 5430: 5426: 5425: 5423: 5422: 5421: 5420: 5407: 5404: 5403: 5401: 5400: 5399: 5398: 5385: 5383: 5376: 5375: 5373: 5372: 5371: 5370: 5358: 5357: 5356: 5337: 5335: 5321: 5317: 5316: 5307: 5305: 5304: 5297: 5290: 5282: 5273: 5272: 5270: 5269: 5261: 5259: 5255: 5254: 5252: 5251: 5243: 5241: 5237: 5236: 5233: 5232: 5230: 5229: 5222: 5215: 5208: 5201: 5193: 5191: 5185: 5184: 5182: 5181: 5171: 5166: 5161: 5155: 5153: 5144: 5138: 5137: 5128: 5126: 5125: 5118: 5111: 5103: 5094: 5093: 5090: 5089: 5086: 5085: 5083: 5082: 5081: 5080: 5069: 5068: 5067: 5066: 5065: 5064: 5059: 5049: 5044: 5043: 5042: 5037: 5032: 5031: 5030: 5025: 5020: 5012: 5007: 5002: 4997: 4992: 4982: 4968: 4967: 4966: 4965: 4960: 4955: 4941: 4939: 4933: 4932: 4930: 4929: 4924: 4918: 4916: 4907: 4898: 4894: 4893: 4890: 4889: 4887: 4886: 4881: 4876: 4871: 4866: 4861: 4855: 4853: 4849: 4848: 4846: 4845: 4840: 4838:Cerebral edema 4835: 4834: 4833: 4828: 4823: 4818: 4807: 4805: 4799: 4798: 4795: 4794: 4792: 4791: 4790: 4789: 4787:Template:Sleep 4777: 4775: 4771: 4770: 4768: 4767: 4761: 4756: 4750: 4748: 4742: 4741: 4739: 4738: 4732: 4727: 4722: 4716: 4714: 4708: 4707: 4705: 4704: 4698: 4693: 4688: 4682: 4680: 4667: 4659: 4658: 4656: 4655: 4649: 4644: 4639: 4633: 4631: 4625: 4624: 4621: 4620: 4618: 4617: 4615:Leigh syndrome 4611: 4609: 4603: 4602: 4600: 4599: 4588: 4587: 4582: 4577: 4576: 4575: 4561: 4560: 4559: 4554: 4553: 4552: 4536: 4534: 4528: 4527: 4525: 4524: 4519: 4514: 4513: 4512: 4507: 4496: 4495: 4494: 4493: 4488: 4487: 4486: 4476: 4475: 4474: 4464: 4459: 4458: 4457: 4452: 4447: 4442: 4426: 4425: 4424: 4423: 4418: 4413: 4408: 4403: 4402: 4401: 4391: 4390: 4389: 4379: 4378: 4377: 4372: 4367: 4351: 4349: 4342:Extrapyramidal 4335: 4326: 4324:encephalopathy 4315: 4314: 4311: 4310: 4308: 4307: 4302: 4297: 4296: 4295: 4284: 4282: 4275: 4274: 4272: 4271: 4270: 4269: 4259: 4254: 4253: 4252: 4247: 4242: 4237: 4226: 4224: 4215: 4209: 4208: 4201:nervous system 4198: 4196: 4195: 4188: 4181: 4173: 4164: 4163: 4160: 4159: 4148: 4137: 4126: 4111: 4095: 4090: 4089: 4087: 4086:Classification 4080: 4079: 4066: 4053: 4042: 4031: 4020: 4007: 4006:External links 4004: 4003: 4002: 3957: 3956: 3947: 3938: 3915: 3892: 3869: 3831: 3829: 3826: 3823: 3822: 3773: 3746:(8): 1111–24. 3730: 3699: 3672:(3): 195–216. 3656: 3605: 3578:(2): 525–529. 3562: 3537: 3519: 3501: 3483: 3432: 3399: 3375: 3351: 3336:"EU/3/18/2059" 3326: 3302: 3277: 3228: 3179: 3153: 3128: 3103: 3064: 3013: 2986: 2937: 2922: 2907: 2886: 2864: 2842: 2820: 2777: 2755: 2733: 2711: 2694: 2672: 2650: 2628: 2625:www.ataxia.org 2617: 2586: 2537: 2501: 2450: 2407: 2386: 2332: 2308: 2290: 2272: 2271: 2269: 2266: 2240: 2239:Rehabilitation 2237: 2184:(FDA) and the 2176:(FDA) and the 2163: 2160: 2101: 2098: 2096: 2093: 2090: 2089: 2087: 2074: 2069: 2065: 2064: 2062: 2049: 2044: 2040: 2039: 2037: 2024: 2019: 2015: 2014: 2012: 1999: 1994: 1990: 1989: 1984: 1982: 1973: 1966: 1965: 1963: 1950: 1945: 1941: 1940: 1938: 1925: 1920: 1916: 1915: 1913: 1900: 1895: 1891: 1890: 1888: 1875: 1870: 1866: 1865: 1863: 1850: 1845: 1839: 1838: 1829: 1816: 1814: 1810: 1809: 1807: 1794: 1789: 1785: 1784: 1782: 1769: 1764: 1760: 1759: 1757: 1744: 1739: 1735: 1734: 1732: 1719: 1714: 1710: 1709: 1707: 1694: 1689: 1685: 1684: 1682: 1669: 1664: 1660: 1659: 1657: 1644: 1639: 1635: 1634: 1632: 1619: 1614: 1610: 1609: 1607: 1594: 1589: 1585: 1584: 1582: 1569: 1564: 1560: 1559: 1557: 1544: 1539: 1535: 1534: 1532: 1519: 1514: 1510: 1509: 1507: 1494: 1489: 1485: 1484: 1482: 1469: 1464: 1460: 1459: 1457: 1444: 1439: 1435: 1434: 1432: 1419: 1414: 1410: 1409: 1407: 1394: 1389: 1385: 1384: 1382: 1369: 1364: 1360: 1359: 1357: 1344: 1339: 1335: 1334: 1332: 1319: 1314: 1310: 1309: 1307: 1297:Disease ID 668 1294: 1289: 1285: 1284: 1281: 1278: 1273: 1209: 1208: 1203: 1201: 1198: 1195: 1192: 1188: 1187: 1182: 1180: 1177: 1174: 1171: 1167: 1166: 1159: 1154: 1148:proprioception 1122:gait and limb 1120: 1117: 1114: 1108: 1107: 1104: 1101: 1090:poor cognition 1083: 1080: 1077: 1066: 1065: 1062: 1059: 1035: 1032: 1029: 1023: 1022: 1019: 1016: 1003: 1000: 997: 982: 981: 974: 971: 969: 967: 965: 957: 956: 953: 950: 938: 935: 930: 922: 921: 918: 915: 897: 892: 887: 879: 878: 875: 872: 867: 860: 857: 846: 845: 838: 835: 813: 810: 805: 797: 796: 793: 790: 783: 780: 775: 767: 766: 758:Chromosome 22q 755: 750: 741: 738: 735: 727: 726: 719: 716: 711:motion of the 699: 696: 691: 683: 682: 671: 668: 658: 653: 650:3rd–4th decade 648: 640: 639: 624: 621: 606: 603: 600:5th–6th decade 598: 587: 586: 581: 578: 572: 569: 566:3rd–4th decade 564: 556: 555: 553:Chromosome 16q 550: 547: 534: 531: 528:4th–7th decade 526: 518: 517: 510: 499: 498:slow saccades 473: 468: 463: 455: 454: 447: 442: 427: 422: 419:3rd–4th decade 417: 409: 408: 397: 394: 382: 377: 372: 361: 360: 352: 351:Common origin 349: 346: 341: 336: 296: 295:Classification 293: 291: 288: 287: 286: 279: 272: 270: 263: 256: 253: 252: 216: 209:spastic ataxia 193: 179:Many types of 148: 145: 112: 109: 80: 79: 66: 60: 59: 52: 51: 43: 42: 39: 35: 34: 26: 24: 14: 13: 10: 9: 6: 4: 3: 2: 5925: 5914: 5913:Rare diseases 5911: 5909: 5906: 5904: 5901: 5899: 5896: 5894: 5891: 5890: 5888: 5875: 5874: 5867: 5855: 5852: 5851: 5850: 5849: 5845: 5844: 5841: 5833: 5830: 5829: 5828: 5827: 5823: 5819: 5816: 5815: 5814: 5813: 5809: 5808: 5806: 5803: 5799: 5791: 5787: 5784: 5783: 5782: 5781: 5777: 5773: 5770: 5769: 5768: 5767: 5763: 5762: 5760: 5757: 5753: 5745: 5742: 5741: 5740: 5739: 5735: 5731: 5728: 5727: 5726: 5725: 5721: 5720: 5718: 5715: 5711: 5708: 5706: 5702: 5690: 5687: 5686: 5685: 5684: 5680: 5679: 5677: 5674: 5670: 5662: 5659: 5658: 5657: 5656: 5652: 5651: 5649: 5646: 5642: 5634: 5631: 5630: 5629: 5628: 5624: 5623: 5621: 5618: 5614: 5606: 5603: 5602: 5601: 5600: 5596: 5595: 5593: 5590: 5586: 5583: 5581: 5577: 5565: 5562: 5561: 5560: 5559: 5555: 5551: 5550:Choroideremia 5548: 5547: 5546: 5545: 5541: 5540: 5537: 5529: 5526: 5525: 5524: 5523: 5519: 5518: 5515: 5507: 5504: 5503: 5502: 5501: 5497: 5496: 5493: 5490: 5488: 5484: 5472: 5469: 5468: 5467: 5466: 5462: 5458: 5455: 5454: 5453: 5452: 5448: 5444: 5441: 5440: 5439: 5438: 5434: 5433: 5431: 5427: 5419: 5416: 5415: 5414: 5413: 5409: 5408: 5405: 5397: 5394: 5393: 5392: 5391: 5387: 5386: 5384: 5381: 5377: 5369: 5366: 5365: 5364: 5363: 5359: 5355: 5352: 5351: 5350: 5349: 5344: 5343: 5339: 5338: 5336: 5333: 5329: 5325: 5322: 5318: 5314: 5310: 5303: 5298: 5296: 5291: 5289: 5284: 5283: 5280: 5267: 5263: 5262: 5260: 5256: 5249: 5245: 5244: 5242: 5238: 5227: 5223: 5220: 5216: 5213: 5209: 5206: 5202: 5199: 5195: 5194: 5192: 5190: 5186: 5179: 5175: 5172: 5170: 5167: 5165: 5162: 5160: 5157: 5156: 5154: 5152: 5148: 5145: 5143: 5142:Trinucleotide 5139: 5135: 5131: 5124: 5119: 5117: 5112: 5110: 5105: 5104: 5101: 5079: 5076: 5075: 5074: 5071: 5070: 5063: 5060: 5058: 5055: 5054: 5053: 5050: 5048: 5045: 5041: 5038: 5036: 5033: 5029: 5026: 5024: 5021: 5019: 5016: 5015: 5013: 5011: 5008: 5006: 5003: 5001: 4998: 4996: 4993: 4991: 4988: 4987: 4986: 4983: 4981: 4978: 4977: 4976: 4974: 4970: 4969: 4964: 4961: 4959: 4956: 4954: 4951: 4950: 4949: 4947: 4943: 4942: 4940: 4938: 4934: 4928: 4925: 4923: 4920: 4919: 4917: 4915: 4911: 4908: 4906: 4902: 4899: 4895: 4885: 4882: 4880: 4877: 4875: 4872: 4870: 4867: 4865: 4864:Reye syndrome 4862: 4860: 4857: 4856: 4854: 4850: 4844: 4841: 4839: 4836: 4832: 4829: 4827: 4824: 4822: 4819: 4817: 4816:Hydrocephalus 4814: 4813: 4812: 4809: 4808: 4806: 4804: 4800: 4788: 4784: 4783: 4782: 4779: 4778: 4776: 4772: 4766: 4762: 4760: 4757: 4755: 4752: 4751: 4749: 4747: 4743: 4737: 4733: 4731: 4728: 4726: 4723: 4721: 4718: 4717: 4715: 4713: 4709: 4703: 4699: 4697: 4694: 4692: 4689: 4687: 4684: 4683: 4681: 4679: 4675: 4671: 4668: 4666: 4660: 4654: 4650: 4648: 4645: 4643: 4640: 4638: 4635: 4634: 4632: 4630: 4629:Demyelinating 4626: 4616: 4613: 4612: 4610: 4608: 4604: 4598: 4595: 4594: 4593: 4592: 4586: 4583: 4581: 4578: 4574: 4571: 4570: 4569: 4565: 4562: 4558: 4555: 4551: 4548: 4547: 4546: 4543: 4542: 4541: 4538: 4537: 4535: 4533: 4529: 4523: 4520: 4518: 4517:Restless legs 4515: 4511: 4508: 4506: 4503: 4502: 4501: 4498: 4497: 4492: 4489: 4485: 4482: 4481: 4480: 4477: 4473: 4470: 4469: 4468: 4465: 4463: 4460: 4456: 4455:Blepharospasm 4453: 4451: 4448: 4446: 4443: 4441: 4438: 4437: 4436: 4433: 4432: 4431: 4428: 4427: 4422: 4419: 4417: 4414: 4412: 4411:Hemiballismus 4409: 4407: 4404: 4400: 4397: 4396: 4395: 4392: 4388: 4385: 4384: 4383: 4380: 4376: 4373: 4371: 4368: 4366: 4363: 4362: 4361: 4358: 4357: 4356: 4353: 4352: 4350: 4348: 4343: 4339: 4336: 4334: 4330: 4327: 4325: 4320: 4316: 4306: 4303: 4301: 4298: 4294: 4291: 4290: 4289: 4286: 4285: 4283: 4281: 4276: 4268: 4265: 4264: 4263: 4262:Brain abscess 4260: 4258: 4255: 4251: 4248: 4246: 4243: 4241: 4238: 4236: 4233: 4232: 4231: 4228: 4227: 4225: 4223: 4219: 4216: 4214: 4210: 4206: 4202: 4194: 4189: 4187: 4182: 4180: 4175: 4174: 4171: 4158: 4154: 4153: 4149: 4147: 4143: 4142: 4138: 4136: 4132: 4131: 4127: 4125: 4121: 4120: 4116: 4112: 4110: 4106: 4105: 4101: 4097: 4096: 4093: 4088: 4084: 4078: 4077:Rare Diseases 4075:'s Office of 4074: 4070: 4067: 4065: 4064:Rare Diseases 4062:'s Office of 4061: 4057: 4054: 4052: 4048: 4047: 4043: 4041: 4037: 4036: 4032: 4030: 4026: 4025: 4021: 4019: 4015: 4014: 4010: 4009: 4005: 3999: 3995: 3991: 3987: 3982: 3977: 3973: 3969: 3965: 3960: 3959: 3955: 3951: 3948: 3946: 3942: 3939: 3937: 3931: 3927: 3923: 3922: 3916: 3914: 3908: 3904: 3900: 3899: 3893: 3891: 3885: 3881: 3877: 3876: 3870: 3866: 3862: 3858: 3857: 3848: 3844: 3840: 3839: 3833: 3832: 3827: 3818: 3814: 3810: 3806: 3801: 3796: 3793:(5): 515–22. 3792: 3788: 3784: 3777: 3774: 3769: 3765: 3761: 3757: 3753: 3749: 3745: 3741: 3734: 3731: 3720:on 2012-07-12 3716: 3709: 3703: 3700: 3695: 3691: 3687: 3683: 3679: 3675: 3671: 3667: 3660: 3657: 3652: 3648: 3643: 3638: 3633: 3628: 3624: 3620: 3616: 3609: 3606: 3601: 3597: 3593: 3589: 3585: 3581: 3577: 3573: 3566: 3563: 3552:on 2019-08-01 3551: 3547: 3541: 3538: 3535: 3531: 3530: 3523: 3520: 3517: 3513: 3512: 3505: 3502: 3499: 3495: 3494: 3487: 3484: 3479: 3475: 3470: 3465: 3460: 3455: 3451: 3447: 3443: 3436: 3433: 3427: 3422: 3418: 3414: 3410: 3403: 3400: 3389: 3385: 3379: 3376: 3365: 3361: 3355: 3352: 3341: 3337: 3330: 3327: 3316: 3312: 3306: 3303: 3292:on 2019-08-01 3291: 3287: 3281: 3278: 3273: 3269: 3264: 3259: 3255: 3251: 3247: 3243: 3239: 3232: 3229: 3224: 3220: 3215: 3210: 3206: 3202: 3198: 3194: 3190: 3183: 3180: 3168: 3164: 3157: 3154: 3138: 3132: 3129: 3117: 3116:Investors Hub 3113: 3107: 3104: 3099: 3093: 3079:on 2016-11-19 3078: 3074: 3068: 3065: 3060: 3056: 3051: 3046: 3041: 3036: 3032: 3028: 3024: 3017: 3014: 3009: 3005: 3001: 2997: 2990: 2987: 2982: 2978: 2973: 2968: 2964: 2960: 2956: 2952: 2948: 2941: 2938: 2935: 2931: 2926: 2923: 2918: 2914: 2910: 2904: 2900: 2893: 2891: 2887: 2883: 2879: 2875: 2874: 2868: 2865: 2861: 2857: 2853: 2852: 2846: 2843: 2839: 2835: 2831: 2830: 2824: 2821: 2816: 2812: 2808: 2804: 2800: 2796: 2792: 2788: 2781: 2778: 2774: 2770: 2766: 2765: 2759: 2756: 2752: 2748: 2744: 2743: 2737: 2734: 2730: 2726: 2722: 2721: 2715: 2712: 2709: 2705: 2704: 2698: 2695: 2691: 2687: 2683: 2682: 2676: 2673: 2669: 2665: 2661: 2660: 2654: 2651: 2647: 2643: 2639: 2638: 2632: 2629: 2626: 2621: 2618: 2607:on 2015-07-27 2603: 2596: 2590: 2587: 2582: 2578: 2573: 2568: 2564: 2560: 2557:(2): 142–67. 2556: 2552: 2548: 2541: 2538: 2533: 2529: 2525: 2521: 2517: 2513: 2505: 2502: 2497: 2493: 2488: 2483: 2478: 2473: 2469: 2465: 2464:J. Biol. Chem 2461: 2454: 2451: 2446: 2442: 2438: 2434: 2430: 2426: 2422: 2418: 2411: 2408: 2402: 2401: 2396: 2390: 2387: 2382: 2378: 2374: 2370: 2365: 2360: 2356: 2352: 2349:(4): 607–15. 2348: 2344: 2336: 2333: 2322: 2318: 2312: 2309: 2304: 2300: 2294: 2291: 2288: 2287: 2282: 2277: 2274: 2267: 2265: 2262: 2258: 2254: 2250: 2245: 2238: 2236: 2234: 2230: 2226: 2222: 2218: 2214: 2210: 2206: 2202: 2197: 2195: 2189: 2187: 2183: 2179: 2175: 2170: 2168: 2161: 2159: 2156: 2152: 2149: 2145: 2141: 2136: 2134: 2130: 2126: 2123: 2122:polyglutamine 2119: 2115: 2111: 2105: 2099: 2094: 2088: 2086: 2085:Rare Diseases 2083:'s Office of 2082: 2078: 2075: 2073: 2070: 2067: 2066: 2063: 2061: 2060:Rare Diseases 2058:'s Office of 2057: 2053: 2050: 2048: 2045: 2042: 2041: 2038: 2036: 2035:Rare Diseases 2033:'s Office of 2032: 2028: 2025: 2023: 2020: 2017: 2016: 2013: 2011: 2010:Rare Diseases 2008:'s Office of 2007: 2003: 2000: 1998: 1995: 1992: 1991: 1988: 1985: 1983: 1981: 1977: 1974: 1972: 1968: 1967: 1964: 1962: 1961:Rare Diseases 1959:'s Office of 1958: 1954: 1951: 1949: 1946: 1943: 1942: 1939: 1937: 1936:Rare Diseases 1934:'s Office of 1933: 1929: 1926: 1924: 1921: 1918: 1917: 1914: 1912: 1911:Rare Diseases 1909:'s Office of 1908: 1904: 1901: 1899: 1896: 1893: 1892: 1889: 1887: 1886:Rare Diseases 1884:'s Office of 1883: 1879: 1876: 1874: 1871: 1868: 1867: 1864: 1862: 1861:Rare Diseases 1859:'s Office of 1858: 1854: 1851: 1849: 1846: 1844: 1841: 1840: 1837: 1833: 1830: 1828: 1827:Rare Diseases 1825:'s Office of 1824: 1820: 1817: 1815: 1812: 1811: 1808: 1806: 1805:Rare Diseases 1803:'s Office of 1802: 1798: 1795: 1793: 1790: 1787: 1786: 1783: 1781: 1780:Rare Diseases 1778:'s Office of 1777: 1773: 1770: 1768: 1765: 1762: 1761: 1758: 1756: 1755:Rare Diseases 1753:'s Office of 1752: 1748: 1745: 1743: 1740: 1737: 1736: 1733: 1731: 1730:Rare Diseases 1728:'s Office of 1727: 1723: 1720: 1718: 1715: 1712: 1711: 1708: 1706: 1705:Rare Diseases 1703:'s Office of 1702: 1698: 1695: 1693: 1690: 1687: 1686: 1683: 1681: 1680:Rare Diseases 1678:'s Office of 1677: 1673: 1670: 1668: 1665: 1662: 1661: 1658: 1656: 1655:Rare Diseases 1653:'s Office of 1652: 1648: 1645: 1643: 1640: 1637: 1636: 1633: 1631: 1630:Rare Diseases 1628:'s Office of 1627: 1623: 1620: 1618: 1615: 1612: 1611: 1608: 1606: 1605:Rare Diseases 1603:'s Office of 1602: 1598: 1595: 1593: 1590: 1587: 1586: 1583: 1581: 1580:Rare Diseases 1578:'s Office of 1577: 1573: 1570: 1568: 1565: 1562: 1561: 1558: 1556: 1555:Rare Diseases 1553:'s Office of 1552: 1548: 1545: 1543: 1540: 1537: 1536: 1533: 1531: 1530:Rare Diseases 1528:'s Office of 1527: 1523: 1520: 1518: 1515: 1512: 1511: 1508: 1506: 1505:Rare Diseases 1503:'s Office of 1502: 1498: 1495: 1493: 1490: 1487: 1486: 1483: 1481: 1480:Rare Diseases 1478:'s Office of 1477: 1473: 1470: 1468: 1465: 1462: 1461: 1458: 1456: 1455:Rare Diseases 1453:'s Office of 1452: 1448: 1445: 1443: 1440: 1437: 1436: 1433: 1431: 1430:Rare Diseases 1428:'s Office of 1427: 1423: 1420: 1418: 1415: 1412: 1411: 1408: 1406: 1405:Rare Diseases 1403:'s Office of 1402: 1398: 1395: 1393: 1390: 1387: 1386: 1383: 1381: 1380:Rare Diseases 1378:'s Office of 1377: 1373: 1370: 1368: 1365: 1362: 1361: 1358: 1356: 1355:Rare Diseases 1353:'s Office of 1352: 1348: 1345: 1343: 1340: 1337: 1336: 1333: 1331: 1330:Rare Diseases 1328:'s Office of 1327: 1323: 1320: 1318: 1315: 1312: 1311: 1308: 1306: 1305:Rare Diseases 1303:'s Office of 1302: 1298: 1295: 1293: 1290: 1287: 1286: 1282: 1280:RareDiseases 1279: 1277: 1274: 1271: 1270: 1267: 1266: 1263: 1259: 1255: 1251: 1247: 1242: 1240: 1236: 1232: 1228: 1224: 1220: 1216: 1207: 1204: 1202: 1199: 1196: 1193: 1190: 1189: 1186: 1183: 1181: 1178: 1175: 1172: 1169: 1168: 1164: 1160: 1158: 1155: 1153: 1152:hyperreflexia 1149: 1145: 1141: 1137: 1133: 1129: 1125: 1121: 1118: 1115: 1113: 1110: 1109: 1105: 1102: 1099: 1095: 1091: 1087: 1084: 1081: 1078: 1075: 1071: 1068: 1067: 1063: 1060: 1057: 1054: 1050: 1046: 1043: 1039: 1036: 1033: 1030: 1028: 1025: 1024: 1020: 1017: 1015: 1011: 1008: 1004: 1001: 998: 995: 991: 987: 984: 983: 979: 975: 972: 970: 968: 966: 963: 959: 958: 954: 951: 949: 946: 942: 939: 936: 931: 928: 924: 923: 919: 916: 913: 909: 905: 901: 898: 893: 888: 885: 881: 880: 876: 873: 871: 868: 865: 862:Depending on 861: 858: 855: 851: 848: 847: 843: 839: 836: 833: 829: 824: 821: 817: 814: 811: 806: 803: 799: 798: 794: 791: 788: 785:Mild, remain 784: 781: 776: 773: 769: 768: 765: 759: 756: 754: 751: 749: 745: 742: 739: 736: 733: 729: 728: 724: 720: 717: 714: 710: 706: 703: 700: 697: 692: 689: 685: 684: 680: 676: 672: 669: 666: 662: 659: 654: 649: 646: 642: 641: 638: 634: 629: 625: 622: 619: 615: 612:, positional 611: 607: 605:>25 years 604: 599: 596: 592: 589: 588: 585: 584:Chromosome 11 582: 579: 577: 573: 571:>25 years 570: 565: 562: 558: 557: 554: 551: 548: 545: 542: 538: 535: 532: 527: 524: 520: 519: 515: 511: 508: 503: 500: 496: 491: 488: 484: 478: 474: 469: 464: 461: 457: 456: 452: 448: 446: 443: 440: 437: 433: 428: 423: 418: 415: 411: 410: 406: 402: 398: 395: 391: 387: 383: 378: 373: 370: 366: 363: 362: 359: 353: 350: 347: 342: 338:Average Onset 337: 334: 333: 330: 328: 323: 319: 317: 313: 312:polyglutamine 308: 306: 302: 294: 289: 283: 276: 271: 267: 260: 255: 250: 246: 242: 238: 234: 230: 226: 222: 217: 214: 210: 206: 202: 198: 194: 191: 187: 182: 178: 177: 176: 174: 170: 166: 162: 158: 154: 146: 144: 142: 137: 135: 131: 126: 122: 118: 110: 108: 106: 102: 98: 94: 90: 86: 76: 70: 67: 65: 61: 57: 53: 49: 44: 40: 36: 31: 19: 5870: 5846: 5824: 5818:ARC syndrome 5810: 5778: 5764: 5736: 5722: 5688: 5681: 5653: 5625: 5597: 5580:Cytoskeleton 5556: 5542: 5520: 5498: 5463: 5449: 5435: 5410: 5388: 5360: 5346: 5340: 5265: 5225: 5218: 5173: 5134:anticipation 5072: 4971: 4944: 4913: 4905:Degenerative 4642:Inflammatory 4589: 4522:Stiff-person 4360:Parkinsonism 4333:Degenerative 4230:Encephalitis 4213:Inflammation 4203:, primarily 4150: 4139: 4128: 4113: 4098: 4044: 4033: 4022: 4011: 3971: 3967: 3920: 3897: 3874: 3855: 3837: 3790: 3786: 3776: 3743: 3739: 3733: 3722:. Retrieved 3715:the original 3702: 3669: 3665: 3659: 3622: 3618: 3608: 3575: 3571: 3565: 3554:. Retrieved 3550:the original 3540: 3527: 3522: 3509: 3504: 3491: 3486: 3449: 3445: 3435: 3416: 3412: 3402: 3391:. Retrieved 3387: 3378: 3367:. Retrieved 3363: 3354: 3343:. Retrieved 3339: 3329: 3318:. Retrieved 3314: 3305: 3294:. Retrieved 3290:the original 3280: 3245: 3241: 3231: 3196: 3192: 3182: 3170:. Retrieved 3166: 3156: 3144:. Retrieved 3131: 3119:. Retrieved 3115: 3106: 3081:. Retrieved 3077:the original 3067: 3030: 3026: 3016: 2999: 2989: 2954: 2950: 2940: 2925: 2898: 2871: 2867: 2849: 2845: 2827: 2823: 2790: 2786: 2780: 2762: 2758: 2740: 2736: 2718: 2714: 2701: 2697: 2679: 2675: 2657: 2653: 2635: 2631: 2620: 2609:. Retrieved 2602:the original 2589: 2554: 2550: 2540: 2515: 2504: 2467: 2463: 2453: 2420: 2416: 2410: 2399: 2389: 2346: 2342: 2335: 2324:. Retrieved 2320: 2311: 2302: 2293: 2284: 2276: 2242: 2198: 2190: 2171: 2165: 2157: 2153: 2137: 2106: 2103: 1987:ORPHA:466794 1265: 1243: 1212: 1142:, spasmodic 1116:40–48 years 1106:FGF14 13q34 608:Downbeating 539:(absence of 536: 481:Gaze-evoked 475:Also called 458:SCA3 (MJD) ( 434:(absence of 431: 384:Hypermetric 326: 324: 320: 309: 298: 196: 185: 150: 138: 114: 97:degenerative 88: 84: 83: 5617:Microtubule 5057:Fazio–Londe 4897:Both/either 4691:Generalised 4550:Early-onset 4545:Alzheimer's 4280:spinal cord 3936:GeneReviews 3932:. NBK54582. 3913:GeneReviews 3890:GeneReviews 3529:NCT03759665 3511:NCT03759639 3493:NCT03759678 3000:GeneReviews 2364:11336/30194 2148:orphan drug 2146:status and 2129:daily tasks 2108:stiffness, 1144:torticollis 1094:dyskinesias 1031:1.5–39 yrs 937:1–40 years 914:disorders) 709:oscillatory 487:oscillatory 161:chromosomal 93:progressive 38:Other names 5887:Categories 5332:Melanosome 4665:paroxysmal 4637:Autoimmune 4430:Dyskinesia 4300:Meningitis 4278:Brain and 4152:DiseasesDB 3909:. NBK1225. 3886:. NBK1154. 3849:. NBK1138. 3724:2012-05-10 3625:: 583507. 3556:2019-08-01 3546:"IntraBio" 3419:(1): 1–5. 3393:2019-08-01 3369:2019-08-01 3345:2019-08-01 3320:2019-08-01 3296:2019-08-01 3286:"IntraBio" 3172:14 October 3146:14 October 3121:14 October 3083:2017-01-26 3033:: 583507. 2917:2007923539 2611:2017-01-25 2423:: 120472. 2326:2024-09-17 2321:rc.umn.edu 2268:References 2253:wheelchair 2144:Fast Track 2114:spasticity 2110:depression 2100:Medication 1832:ORPHA:2074 1797:Disease ID 1194:Adulthood 1128:dysarthria 1079:15–20 yrs 1045:neuropathy 1014:dysarthria 1007:cerebellar 902:(a sudden 834:movement) 787:ambulatory 702:Horizontal 576:cerebellar 541:neurologic 465:4th decade 436:neurologic 374:4th decade 249:DNA repair 153:hereditary 134:cerebellum 56:Cerebellum 5871:See also 4662:Episodic/ 4540:Tauopathy 4491:Akathisia 4479:Myoclonus 4462:Athetosis 4394:Tauopathy 3998:238859984 2884:GeneTests 2862:GeneTests 2840:GeneTests 2775:GeneTests 2753:GeneTests 2731:GeneTests 2692:GeneTests 2670:GeneTests 2648:GeneTests 2532:1546-1718 2445:253156325 2209:Tay-Sachs 2140:trehalose 2095:Treatment 904:twitching 900:Myoclonus 737:36 years 705:nystagmus 652:(0.5–60) 610:nystagmus 537:areflexia 483:nystagmus 432:areflexia 335:SCA Type 290:Diagnosis 69:Neurology 64:Specialty 5756:Caveolae 5673:Spectrin 5418:CDOG IIE 5328:Lysosome 5028:SMALED2B 5023:SMALED2A 4720:Migraine 4712:Headache 4678:epilepsy 4674:Seizures 4532:Dementia 4435:Dystonia 3990:34647648 3952:(OMIM): 3943:(OMIM): 3930:21595125 3907:20301404 3884:20301333 3865:20301295 3847:20301317 3817:23764699 3809:22140200 3768:11008654 3760:19412936 3694:40374830 3686:21321055 3651:24877117 3600:56148131 3592:30547273 3478:27073690 3452:(1): 8. 3272:21952166 3223:26490326 3092:cite web 3059:24877117 3008:25577942 2981:27470939 2932:(OMIM): 2807:14526178 2581:25608779 2518:: 1–10. 2496:32060097 2437:36403298 2381:74661673 2373:24765663 2233:migraine 2213:Sandhoff 1978:(OMIM): 1836:Orphanet 1197:Decades 1176:Decades 1119:Unknown 1082:Unknown 1049:vomiting 1034:Unknown 1010:syndrome 934:(20–66) 891:(12–42) 828:akinesia 779:(15–70) 748:seizures 740:9 years 695:(18–65) 679:Ataxin 7 655:20 years 635:channel 618:Symptoms 602:(19–71) 568:(10–68) 544:reflexes 533:Decades 530:(19–72) 507:Portugal 470:10 years 467:(10–70) 439:reflexes 424:10 years 405:Ataxin 1 386:saccades 381:(10–35) 379:15 years 354:Problems 5645:Kinesin 5264:ATTCT ( 5040:SMA-PME 5035:SMA-PCH 5018:SMALED1 4730:Tension 4725:Cluster 4450:Meige's 4267:Amoebic 4146:D020754 3642:4022207 3469:4828858 3263:3242660 3214:4840549 3050:4022207 2972:5266678 2815:2292926 2572:4454471 2487:7105313 2188:(EMA). 1103:  1061:  1042:sensory 1021:  1018:  1002:  999:  973:  960:SCA17 ( 952:  925:SCA16 ( 917:  908:muscles 896:(1–30) 894:Decades 882:SCA14 ( 874:  837:  812:  809:(8–55) 802:PPP2R2B 800:SCA12 ( 792:  770:SCA11 ( 730:SCA10 ( 718:  713:eyeball 677:, 3p ( 670:  633:Calcium 623:  614:vertigo 595:CACNA1A 580:  549:  523:PLEKHG4 472:(1–20) 426:(1–30) 396:  322:found. 243:during 132:of the 130:atrophy 91:) is a 5826:VPS13B 5812:VPS33B 5724:SNAP29 5683:SPTBN2 5589:Myosin 5522:RAB27A 5390:SEC23A 5246:CCTG ( 4759:Stroke 4573:Pick's 4500:Tremor 4467:Chorea 4135:164400 3996:  3988:  3928:  3905:  3882:  3863:  3845:  3815:  3807:  3766:  3758:  3692:  3684:  3649:  3639:  3598:  3590:  3476:  3466:  3270:  3260:  3221:  3211:  3057:  3047:  3006:  2979:  2969:  2934:609307 2915:  2905:  2813:  2805:  2579:  2569:  2530:  2494:  2484:  2443:  2435:  2379:  2371:  2231:, and 2116:, and 2072:301840 2047:301790 2022:302600 1997:607250 1980:616719 1948:608029 1923:606937 1898:607317 1873:271250 1848:606002 1792:613908 1767:117360 1742:610246 1717:609306 1692:608703 1667:610245 1642:607454 1617:608687 1592:607346 1567:607458 1542:605259 1517:603680 1492:164500 1467:600224 1442:600223 1417:109150 1392:183090 1367:164400 1342:605361 1317:229300 1292:301310 1283:Other 1258:301840 1254:301790 1250:302600 1246:302500 1237:, and 1191:SCA37 1170:SCA36 1124:ataxia 1098:tremor 1086:ataxia 1038:ataxia 978:repeat 948:tremor 932:39 yrs 889:28 yrs 842:repeat 832:muscle 823:tremor 807:33 yrs 777:30 yrs 764:repeat 760:linked 753:Mexico 744:ataxia 732:ATXN10 725:, 13q 723:repeat 693:39 yrs 686:SCA8 ( 675:repeat 643:SCA7 ( 628:repeat 561:SPTBN2 559:SCA5 ( 521:SCA4 ( 516:, 14q 514:repeat 502:Azores 490:motion 453:, 12q 451:repeat 412:SCA2 ( 403:, 6p ( 401:repeat 221:allele 117:ataxia 71:  5738:STX11 5655:KIF5A 5599:MYO5A 5471:CPSQ3 5465:AP4M1 5451:AP3B1 5437:AP1S2 5380:COPII 5224:CAG ( 5217:CTG ( 5210:CTG ( 5203:GAA ( 5196:CGG ( 5073:both: 5005:DSMA1 5000:SMAX2 4995:SMAX1 4975:only: 4948:only: 4852:Other 4774:Other 4686:Focal 4319:Brain 4222:Brain 4157:12339 4109:G11.1 4040:NINDS 4029:NINDS 4018:NINDS 3994:S2CID 3813:S2CID 3764:S2CID 3718:(PDF) 3711:(PDF) 3690:S2CID 3596:S2CID 3193:Brain 3167:Vimeo 3140:(PDF) 2873:sca14 2851:sca12 2829:sca10 2811:S2CID 2708:NINDS 2605:(PDF) 2598:(PDF) 2441:S2CID 2377:S2CID 1971:SCYL1 1272:Name 1262:SCAX1 1239:SCA29 1235:SCA28 1231:SCA26 1227:SCA23 1223:SCA21 1219:SCA20 1215:SCA18 1185:NOP56 1157:China 1112:SCA35 1088:with 1074:FGF14 1070:SCA27 1040:with 1027:SCA25 1005:Mild 994:KCND3 990:SCA22 986:SCA19 927:ITPR1 912:brain 884:PRKCG 864:KCNC3 854:KCNC3 850:SCA13 844:, 5q 772:TTBK2 688:IOSCA 645:ATXN7 630:, 19p 574:Pure 479:(MJD) 460:ATXN3 414:ATXN2 369:ATXN1 356:with 171:, or 147:Cause 5848:DYSF 5780:CAV3 5766:CAV1 5627:SPG4 5558:MLPH 5506:BBS3 5500:ARL6 5429:APC: 5412:COG7 5362:LYST 5348:HPS7 5342:HPS1 4676:and 4387:PKAN 4382:NBIA 4141:MeSH 4130:OMIM 4119:9-CM 3986:PMID 3926:PMID 3903:PMID 3880:PMID 3861:PMID 3843:PMID 3805:PMID 3756:PMID 3682:PMID 3647:PMID 3623:2014 3588:PMID 3474:PMID 3268:PMID 3219:PMID 3174:2017 3148:2017 3123:2017 3098:link 3055:PMID 3031:2014 3004:PMID 2977:PMID 2913:LCCN 2903:ISBN 2803:PMID 2764:sca8 2742:sca7 2720:sca6 2681:sca3 2659:sca2 2637:sca1 2577:PMID 2528:ISSN 2492:PMID 2433:PMID 2369:PMID 2257:gait 2211:and 2203:and 1276:OMIM 1206:DAB1 1163:TGM6 1150:and 1096:and 1056:pain 1051:and 976:CAG 945:hand 943:and 941:Head 920:19q 877:19q 840:CAG 820:hand 818:and 816:Head 795:15q 721:CTG 673:CAG 637:gene 626:CAG 591:SCA6 512:CAG 449:CAG 445:Cuba 399:CAG 365:SCA1 157:gene 151:The 5544:CHM 5487:Rab 4990:SMA 4973:LMN 4946:UMN 4937:MND 4803:CSF 4754:TIA 4399:PSP 4375:NMS 4344:and 4205:CNS 4124:334 4115:ICD 4100:ICD 4073:NIH 4071:at 4060:NIH 4058:at 4038:at 4027:at 4016:at 3976:doi 3934:In 3911:In 3888:In 3851:In 3795:doi 3748:doi 3674:doi 3637:PMC 3627:doi 3580:doi 3576:266 3464:PMC 3454:doi 3421:doi 3258:PMC 3250:doi 3209:PMC 3201:doi 3197:138 3045:PMC 3035:doi 2967:PMC 2959:doi 2955:161 2878:NIH 2876:at 2856:NIH 2854:at 2834:NIH 2832:at 2795:doi 2791:100 2769:NIH 2767:at 2747:NIH 2745:at 2725:NIH 2723:at 2706:at 2686:NIH 2684:at 2664:NIH 2662:at 2642:NIH 2640:at 2567:PMC 2559:doi 2520:doi 2482:PMC 2472:doi 2468:295 2425:doi 2421:443 2359:hdl 2351:doi 2283:at 2081:NIH 2079:at 2056:NIH 2054:at 2031:NIH 2029:at 2006:NIH 2004:at 1957:NIH 1955:at 1932:NIH 1930:at 1907:NIH 1905:at 1882:NIH 1880:at 1857:NIH 1855:at 1834:at 1823:NIH 1821:at 1801:NIH 1799:at 1776:NIH 1774:at 1751:NIH 1749:at 1726:NIH 1724:at 1701:NIH 1699:at 1676:NIH 1674:at 1651:NIH 1649:at 1626:NIH 1624:at 1601:NIH 1599:at 1576:NIH 1574:at 1551:NIH 1549:at 1526:NIH 1524:at 1501:NIH 1499:at 1476:NIH 1474:at 1451:NIH 1449:at 1426:NIH 1424:at 1401:NIH 1399:at 1376:NIH 1374:at 1351:NIH 1349:at 1326:NIH 1324:at 1301:NIH 1299:at 1256:, 1252:, 1248:, 1064:2p 962:TBP 955:8q 906:of 358:DNA 247:or 233:DNA 231:in 159:or 89:SCA 5889:: 5788:, 5311:/ 5132:: 4914:SA 4421:OA 4416:HD 4365:PD 4155:: 4144:: 4133:: 4122:: 4107:: 4104:10 4049:: 3992:. 3984:. 3972:37 3970:. 3966:. 3811:. 3803:. 3791:26 3789:. 3785:. 3762:. 3754:. 3744:24 3742:. 3688:. 3680:. 3670:25 3668:. 3645:. 3635:. 3621:. 3617:. 3594:. 3586:. 3574:. 3472:. 3462:. 3448:. 3444:. 3415:. 3411:. 3386:. 3362:. 3338:. 3313:. 3266:. 3256:. 3246:19 3244:. 3240:. 3217:. 3207:. 3195:. 3191:. 3165:. 3114:. 3094:}} 3090:{{ 3053:. 3043:. 3029:. 3025:. 2975:. 2965:. 2953:. 2949:. 2911:. 2889:^ 2882:UW 2860:UW 2838:UW 2809:. 2801:. 2789:. 2773:UW 2751:UW 2729:UW 2690:UW 2668:UW 2646:UW 2575:. 2565:. 2555:50 2553:. 2549:. 2526:. 2514:. 2490:. 2480:. 2466:. 2462:. 2439:. 2431:. 2419:. 2397:. 2375:. 2367:. 2357:. 2347:21 2345:. 2319:. 2301:. 2235:. 2227:, 2223:, 2219:, 2112:, 1264:). 1241:. 1233:, 1229:, 1225:, 1221:, 1217:, 1138:, 1134:, 1130:, 1126:, 1100:. 1092:, 1076:) 1058:. 1047:, 1012:, 996:) 988:, 964:) 929:) 886:) 856:) 804:) 774:) 746:, 734:) 690:) 681:) 663:, 647:) 597:) 563:) 546:) 525:) 509:) 462:) 441:) 416:) 407:) 371:) 329:. 203:, 175:. 167:, 99:, 95:, 5804:: 5758:: 5716:: 5675:: 5647:: 5619:: 5591:: 5382:: 5345:– 5334:: 5330:/ 5301:e 5294:t 5287:v 5268:) 5250:) 5228:) 5221:) 5214:) 5207:) 5200:) 5180:) 5176:( 5122:e 5115:t 5108:v 4566:/ 4321:/ 4192:e 4185:t 4178:v 4117:- 4102:- 4092:D 4000:. 3978:: 3867:. 3819:. 3797:: 3770:. 3750:: 3727:. 3696:. 3676:: 3653:. 3629:: 3602:. 3582:: 3559:. 3480:. 3456:: 3450:3 3429:. 3423:: 3417:2 3396:. 3372:. 3348:. 3323:. 3299:. 3274:. 3252:: 3225:. 3203:: 3176:. 3150:. 3125:. 3100:) 3086:. 3061:. 3037:: 3010:. 2983:. 2961:: 2919:. 2880:/ 2858:/ 2836:/ 2817:. 2797:: 2771:/ 2749:/ 2727:/ 2688:/ 2666:/ 2644:/ 2614:. 2583:. 2561:: 2534:. 2522:: 2498:. 2474:: 2447:. 2427:: 2383:. 2361:: 2353:: 2329:. 2305:. 2207:( 1072:( 992:( 852:( 825:, 593:( 505:( 367:( 251:. 215:. 87:( 20:)

Index

Spinocerebellar ataxias

Cerebellum
Specialty
Neurology
Edit this on Wikidata
progressive
degenerative
genetic disease
at any given time
ataxia
genetic disorders
incoordination of gait
atrophy
cerebellum
mental capacity
hereditary
gene
chromosomal
autosomal dominant
autosomal recessive
X-linked manner
autosomal dominant cerebellar ataxias
central nervous system
Friedreich ataxia
ataxia-telangiectasia
spastic ataxia
olivopontocerebellar atrophy
allele
genetic anticipation

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑